Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Seattle Genetics ends clinical trial of leukemia drug after ‘a higher rate of deaths’
Seattle Genetics ends clinical trial of leukemia drug after ‘a higher rate of deaths’
Seattle Genetics ends clinical trial of leukemia drug after ‘a higher rate of deaths’
Submitted by
admin
on June 19, 2017 - 11:38pm
Source:
Seattle Times, WA
News Tags:
Seattle Genetics
clinical trials
vadastuximab talirine
AML
acute myeloid leukemia
Headline:
Seattle Genetics ends clinical trial of leukemia drug after ‘a higher rate of deaths’
Do Not Allow Advertisers to Use My Personal information
